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Background: A new physiopathologic concept within superficial venous insufficiency (SVI) describes ascending progres-
sion from the collaterals to the saphenous veins (SV), leading to a treatment that aims to remove the varicose reservoir and
not the SVs. This study reports the midterm results of this therapeutic approach.
Methods: This is a retrospective study of patients treated for varices by phlebectomy with conservation of a refluxing SV
before July 2004. We evaluated the varicose reservoir by determining the number of zones to be treated (NZT); each
lower limb was divided into 32 zones in the preoperative mapping. We performed a clinical and duplex ultrasound
examination after 6 months and 1 year, and then once a year until year 4.
Results: Amongst 811 lower limbs operated on for first-time varicose veins, 303 in 221 patients (55 men; 166 women),
mean age, 52.7 years (range, 20-93 years), were treated by phlebectomy, with conservation of a refluxing SV. All lower
limbs operated on presented preoperative SV reflux >0.5 seconds: great SV (GSV), 85.8%; small SV (SSV), 11.9%; and
GSV and SSV, 2.3%. The average NZT was 6.05 (range, 2-10). SV reflux was reduced to< 0.5 seconds in 69.6%, 69.2%,
68.7%, 68.0%, and 66.3% of limbs, respectively, after 6 months, 1, 2, 3, and 4 years of follow-up. Symptoms improved or
disappeared in 84.2%, 84.2%, 83.4%, 81.4%, and 78.0% of limbs at each annual check-up until year 4. Freedom of varices
recurrence was 95.5%, 94.6%, 91.5%, and 88.5%, respectively at 1, 2, 3, and 4 years. When the NZT was >7, the
postoperative varicose recurrence was more frequent (odds ratio, 6.82; P  .0001), and the postoperative elimination of
SV reflux was more frequent (odds ratio, 4; P .037) as was symptoms improvement (odds ratio, 2.91; P .004). When
an ostiotruncal SV reflux extended to the malleolus preoperatively, the elimination of the SV reflux was less frequent
(47.6% vs 70.3%; P < .05).
Conclusion: Ablation of the varicose reservoir with conservation of a refluxing SV can be an effective treatment in the
midterm for the signs and symptoms of SVI and leads to nonsignificant SV reflux in more than two of three cases. The
extent of the varicose reservoir ablation is the key factor determining the hemodynamic and clinical efficacy of this more
limited surgical approach. (J Vasc Surg 2009;50:107-18.)The traditional physiopathologic concept of primary
varicose disease is based on a hypothesis of retrograde
hemodynamic evolution of superficial venous insufficiency,
which describes a development of the reflux from connec-
tions between the deep venous system and the superficial
venous system, particularly in the region of the confluence
with the saphenous veins (SVs). According to this theory,
the occurrence of a reflux in the region of the terminal valve
of the SV is the key point in the evolution, with the reflux
extending gradually in a retrograde fashion or descending
along the SV, ultimately reaching the suprafascial collateral
veins on which the varices develop. This description was
disseminated as early as 1890 by Trendelenburg1 and was
repeated much later in a more accurate manner by Lud-
brook.2
This description was also challenged regularly by stud-
ies describing the presence of varices that were not neces-
sarily accompanied by SV incompetence.3-11 Nevertheless,
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having as a consequence the dogma of the elimination of
the SV and of all of the points of reflux, starting with the
deep veins (including, in particular, in the region of the
saphenous confluence), by high ligation at the deep vein
level, in accordance with the principles described by
Mayo12 and Babcock13 at the start of the 20th century.
The advent of endovenous SV ablation techniques by
radiofrequency (RFA) or laser (EVLA) did not modify the
descending physiopathologic concept, because these tech-
niques apply the same therapeutic principle as the tradi-
tional surgery, with the only difference consisting of the
absence of high ligation at the saphenous confluence. Par-
adoxically, the good midterm results of the endovenous
techniques, despite the absence of the direct obliteration of
the ostial reflux by high ligation,14-16 led to renewed ques-
tions regarding the relevance of the descending hemody-
namic concept.
These questions were supported by studies, including
many earlier ones, based on better hemodynamic knowl-
edge, thanks to the progress of ultrasound examina-
tions.5-11 Certain publications also suggested the hypoth-
esis of a so-called ascending or multifocal development of
varicose disease starting from the distal superficial venous
network.6,7,9-11,17,18 Thus, the minimally invasive surgical
107
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voir by phlebectomy, as described by Muller,19 is enjoying
renewed attention, including with the conservation of a
refluxing SV.20 We describe here our midterm clinical and
hemodynamic experience with this more limited surgical
approach.
MATERIALS AND METHODS
This retrospective study was conducted at two surgical
centers (Riviera Vein Institute in Nice, and Charcot Clinic
in Lyon). Two surgeons participated in the study, one at
each facility (P. P. in Nice and B. R. in Lyon).
Preoperative data. The preoperative data for the pa-
tients who underwent operations consecutively for the first
time for varices between May 2003 and July 2004 were
reviewed, in terms of age, sex, CEAP class C, the presence
of symptoms (pain, heaviness, a swelling sensation, pruri-
tus, night cramps, restlessness, tingling, heat) regardless of
their location on the limb, and their repercussions accord-
ing to the Venous Disability Score21: 0 for “asymptom-
atic”; 1 for “symptomatic but able to perform normal
activities without compressive therapy”; 2 for “can perform
normal activities only with compression and/or limb eleva-
tion”; 3 for “unable to perform normal activities even with
compression and/or limb elevation.”
The hemodynamic and anatomic data were recorded
with duplex ultrasound (DUS) examination performed
with the patient standing upright: the reflux was evaluated
by DUS scanning of both the great (GSV) and small SV
(SSV), using the manual venous flushing maneuver in the
calf region, and the diameter of the SV was measured by
DUS in the saphenous confluence region. The reflux in the
SV was recorded at the moment of the sudden release of
manual compression of the calf. Under these conditions, a
reflux was considered to be pathologic if the reflux duration
was0.5 seconds for the superficial veins and 1 second for
the deep veins. The reflux duration was measured with
0.1-second accuracy. The measurement was repeated twice
by the same operator in both facilities (R. B. in Nice and
Lyon). A mean was calculated for the reflux duration mea-
surements.
The extent of the varicose reservoir was evaluated ac-
cording to the number of zones to be treated (NZT) by
phlebectomy, with each limb divided into 32 zones in the
preoperative clinical mapping (Fig 1). Each limb was di-
vided into four surface areas (anterior, posterior, lateral,
andmedial), and then each surface area was divided in eight
zones: the thigh into three zones (the upper third, middle
third, and lower third), the calf into three zones (the upper
third, middle third, and lower third), plus one zone for the
knee and one zone for the foot. This arrangement reflects
our clinical examination technique, in which we examine
each lower limb in a standing position, from the front, from
the back, and from each of its profiles (medial and lateral).
Surgical procedure. The decision to preserve the SV
was made subjectively by the surgeon for patients who
appeared to be at a less advanced stage of the SV disease,
both hemodynamically (eg, with a continent ostial valveand partial SV reflux) as well as clinically (eg, with an
absence of symptoms or trophic disorders).
The cost of the procedures was calculated according to
the reimbursement of medical fees and hospitalization ex-
penses by the insurance companies.
Follow-up. As specified by the protocol of follow-up
usually used in the two centers involved in this study, the
patients were seen postoperatively at 1 month and 6
months, and then once a year for the following evaluations:
● SV by DUS, according to the same methods used in
the preoperative examination. Reflux was deemed
nonsignificant if the reflux duration was0.5 seconds;
considerably reduced if the postoperative reflux dura-
tion was reduced by 50% compared with the preop-
erative reflux duration, and unchanged in the other
cases.
● CEAP class C according to the clinical examination;
the presence of recurrent varicose veins included the
Recurrent Varices After Surgery (REVAS) criteria22
(ie, the presence of visible or palpable varices 3 mm
in a limb that had previously undergone an operation).
● Evolution of the symptoms that were experienced,
according to the patient questionnaire (relief, un-
changed or worse) and according to the Venous Dis-
ability Score.
● Evolution of esthetics, according to the patient ques-
tionnaire (improved, unchanged or worse).
Statistical analysis. The means for continuous vari-
ables were calculated with a standard deviation of .05 at the
 threshold. The qualitative bivariate comparisons used the
2 test, and the means comparisons used the t test. Mid-
term survival was determined using Kaplan-Meier life-table
analysis. The observation of linear link between the NZT
and the other qualitative variables was assessed using the
linear trend 2 test (extended Mantel-Haenszel 2 test).
Fig 1. Preoperative clinical mapping shows the limb divided in 32
zones. Example shows seven zones to be treated for varices.Statistical analysis was performed using Epi Info (Centers
icable
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XLSTAT software (Addinsoft France, Paris, France). The
significance level for all of the comparisons was set at
P  .05.
RESULTS
Population. FromMay 2004 to July 2005, 811 lower
limbs in 599 patients (444 women; 155 men) underwent
consecutive operations for the first time on varices. Patients
were a mean age of 53.10  0.96 years (range, 20-86
years). Of these 811 lower limbs, 573 (70.7%) presented
reflux along at least one saphenous axis (485 GSV; 84 SSV;
4 GSV and SSV), whereas 238 (29.3%) had isolated varices
with no saphenous reflux. No deep venous refluxes were
diagnosed.
In the 573 lower limbs with SV reflux, ablation of
varicosities with conservation of a preoperatively refluxing
SV, so-called ambulatory selective varices ablation under
local anesthesia (ASVAL) was performed 303 times
(52.9%), whereas high ligation associated with stripping
(HLS) of the SV was performed in the other 270 cases
(47.1%). No RFA or EVLA treatments were performed
during the study period.
The comparison of the cohorts undergoing ASVAL
and HLS revealed significant differences (Table I): In the
ASVAL group the mean age was younger, the proportion
of women was greater, the mean body mass index (BMI)
was lower, the CEAP C4 to C6 class was less frequent, the
Table I. Cohorts operated on by ambulatory selective var
ligation and stripping
Variableb ASVAL
Limbs, No. 303
Patients, No. 221
Age, y 52.7  1.55 (20-83)
Female, % 75.1
BMI 23.8  0.44
CEAP classification, %
C0-C1 0
C2 85.80
C3 5.30
C4 8.90
C5-C6 0
NZT 6.05  0.15
Asymptomatic limbs, % 33.7
VDS for LSBS 1.30  .08
Saphenous reflux, %
GSV 88.10
SSV 11.90
GSV  SSV 0
Saphenous confluence
Competence, % 15.80
Diameter, mm 7.05  0.27
Whole SV reflux, %c 8.60
ASVAL, Ambulatory selective varices ablation under local anesthesia; BMI,
LSBS, limbs symptomatic before surgery;NZT, number of zones to be treat
aPhlebectomy with preservation of a refluxing saphenous vein.
bContinuous data are presented with the standard deviation (range), if appl
cFrom the confluence to the malleolus.mean varicose reservoir was smaller (the mean NZT waslower), and the incidence of asymptomatic lower limbs was
higher; however, the mean Venous Disability Score was
equal for symptomatic limbs in both groups. The hemody-
namic status of the lower limbs undergoing ASVAL also
revealed significant differences: the saphenous confluence
was continent more often, its diameter was smaller, and the
saphenous reflux was less often complete from the ostium
to the malleolus.
The calculation of the cost of the procedures reim-
bursed by the insurance companies was €229,334.64 for
the ASVAL group, which was a significant savings com-
pared with €337,468.20 for theHLS group. Themean cost
for each procedure was €758.88  10.20 for ASVAL vs
€1143.96  12.42 for HLS (P  .05), yielding a mean
saving of €387.08  14.35 per procedure for the ASVAL
group.
We chose to include in the retrospective study only the
patients who underwent ASVAL, with an analysis of the
operating protocol and postoperative progress. Our intent
was to report the results obtained by the patients treated
with ablation of the varices and conservation of the reflux-
ing SV. Furthermore, we determined that the significant
demographic and clinical differences between the ASVAL
and HLS groups represented a major bias for the compar-
ison of the results obtained in the two groups.
Operation and postoperative follow-up. The ASVAL
was done with phlebectomies through staged incisions
under tumescent local anesthesia (150mg of lidocaine with
blation under local anesthesiaa compared with high
HLS P
270
230
54.5  1.66 (20-86) .002
65.20 .05
25.2  0.51 .0006
0.80
76.6 .05
4.90
15. .05
2.10
7.19  0.21 .00001
21.5 .05
1.32  0.08 .68
80.70
17.80 .05
1.50
7.80 .05
8.40  0.31 .0001
44.40 .05
mass index; GSV, great saphenous vein; HLS, high ligation and stripping;
, small saphenous vein; SV, saphenous vein; VDS, Venous Disability Score.
.ices a
Body
ed; SSV75 g of epinephrine for each 500 mL of isotonic bicar-
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RFA or EVLA, was performed for the treatment of varicos-
ities. The 303 lower limbs were treated by ASVAL over the
course of 288 operations. All operations were on an outpa-
tient basis. The mean duration was 51.80  1.77 minutes
(range, 20-90 minutes), and the mean number of incisions
was 31.10  1.33 (range, 15-77). Tumescent local anes-
thesia was used for all operations. Postoperative anticoag-
ulant treatment by heparin therapy was administered in two
patients (0.7%) as a change from long-term oral anticoag-
ulation treatment.
All of the lower limbs operated on by ASVAL were
reviewed during the first postoperative consultation at day
8, and postoperative thrombosis of the GSV was observed
in three patients (1%). In two patients the GSV presented a
preoperative segmental dilatation 10 mm (11 and 15
mm), and in one patient the GSV presented a preoperative
major difference in diameter (10 mm) on both sides of
the resected varicose collateral vein. One patient was
treated by high ligation to avoid the extension of a throm-
bus in the femoral vein, and the other two patients were
treated medically with heparin therapy. No other postop-
erative complications were observed.
A total of 280 lower limbs (92.4%) were seen again
beyond the first month postoperatively, with a mean
follow-up duration of 32.4 months (range, 3-48; median,
35.4 months).
Hemodynamic and anatomic evolution. Reflux was
not significant in the SV (reflux duration 0.5 seconds)
after 6 months and after 1, 2, 3, and 4 years by life-table
Fig 2. Kaplan-Meier analysis shows the presence of no
after ambulatory selective varices ablation under local ane
time point.analysis in 69.6%, 69.2%, 68.7%, 68.0%, and 66.3% oflimbs, respectively (Fig 2). The saphenous reflux was dra-
matically reduced (reflux duration 0.5 seconds, or post-
operatively 50% preoperatively) in 92.1%, 92.1%, 92.1%,
91.6%, and 90.7% of limbs, at 6 months and after 1, 2, 3
and 4 years by life-table analysis (Fig 3).
The diameter of the SV significantly decreased, as mea-
sured at the saphenous confluence, in 243 lower limbs after
6 months (5.87  0.23 mm vs 7.87  0.25 mm preoper-
atively; P  .0001), and the magnitude of this reduction
was correlated with the improvement in the hemodynamics
of the SV (Table II).
Evolution of signs and symptoms. The proportion
of the 171 limbs symptomatic before surgery and that were
tracked with a symptoms relief was 84.2%, 84.2%, 83.4%,
81.4%, and 78.0%, respectively, at 6 months, and at 1, 2, 3,
and 4 years by life-table analysis (Fig 4). The mean Venous
Disability Score was significantly lower at month 6 postop-
eratively for the symptomatic limbs (0.64 0.08 vs 1.30
0.08 preoperatively; P  .001), and remained so through-
out the follow-up period until the year 4: 0.63 0.08 at 1
year, 0.64  0.09 at 2 years, 0.69  0.09 at 3 years, and
0.68  0.11 at 4 years.
An esthetic improvement was asserted by 93.9% of
patients at 6 months and by 93.2%, 92.7%, 91.6% and
89.9% at 1, 2, 3, and 4 years by life-table analysis (Fig 5).
Freedom of varices recurrence in the treated lower
limbs at 6 months and at 1, 2, 3, and 4 years after life table
analysis was 98.9%, 95.5%, 94.6%, 91.5%, and 88.5%, re-
spectively (Fig 6).
Among the 24 lower limbs that presented a varicose
ificant saphenous reflux (reflux duration 0.5 seconds)
ia. Error bars represent 95% confidence intervals at eachnsign
sthesrecurrence during the follow-up according to the REVAS22
nce in
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pared with the preoperative situation in three limbs. The
reflux was considerably reduced (postoperative 50% pre-
operative) in four limbs, whereas no reflux was noted
(reflux duration 0.5 seconds) in 17. An incompetent
perforator vein with a significant reflux (0.5 seconds) and
with a diameter of 3 mm was present in three of the 17
limbs with localized recurrent varices. No indications of
neovascularization were detected by the Doppler echo-
graphic examination of the recurrence zones, all of which
affected the degradation of other collateral vessels. Further-
more, no deep venous reflux was observed in the lower
limbs that exhibited a recurrence.
Additional procedures during the follow-up.
Freedom of a secondary major procedure (surgical proce-
dure or echo-guided foam sclerotherapy) after life-table
Fig 3. Kaplan-Meier analysis shows for presence of d
seconds or postoperative reflux duration50% preoperat
under local anesthesia. Error bars represent 95% confide
Table II. Evolution of the diameter of the saphenous con
anesthesiaa
Variable No.
Mean
Pre-op
Whole cohort controlled 243 7.87  0.25
Unchanged SRb 19 9.56  1.10
Considerably reduced SRc 63 6.56  0.39
Reflux duration 0.5 s 161 8.18  0.23
SC, Saphenous confluence; SR, saphenous reflux.
aPhlebectomy with preservation of a refluxing saphenous vein.
bPostoperative reflux duration 50% preoperative reflux duration.
cPostoperative reflux duration 50% preoperative reflux duration.analysis was 98.2%, 97.1%, 97.1%, 97.1%, 89.8%, respec-tively, at 6 months, and at 1, 2, 3, and 4 years (Fig 7). A
major additional procedure was performed in 10 limbs
during the follow-up period:
● Three limbs required the suppression of a SV in which
the reflux was unchanged compared with preopera-
tively. In one limb this was by echo-guided foam
sclerotherapy of the GSV due to the persistence of
symptomatic reflux with no varicose recurrence. Two
limbs underwent HLS of the SSV, after 6 and 18
months, due to symptomatic varicose recurrence.
● In seven, the procedure was limited to a new phlebec-
tomy for cosmetic reasons after 12, 18, 20, 24, 28, 30,
and 36 months, due to an asymptomatic varicose
recurrence.
In 14 of 24 limbs with recurrence, no additional pro-
ically reduced saphenous reflux (reflux duration 0.5
flux duration) after ambulatory selective varices ablation
tervals at each time point.
ce after ambulatory selective varices ablation under local
iameter, mm
Reduction, % PPost-op (6-mon)
5.87  0.23 25 .0001
8.26  1.13 13.5 .0001
5.06  0.33 22.7 .0001
5.64  0.23 31.7 .0001ramat
ive refluen
SC dcedure was performed because of the very limited nature of
at ea
at ea
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nience for the patient.
None of the 179 limbs in which reflux became non-
significant (reflux duration 0.5 seconds) as of the first
postoperative examination (performed 6 months after
Fig 4. Kaplan-Meier analysis shows for symptoms re
anesthesia. Error bars represent 95% confidence intervals
Fig 5. Kaplan-Meier analysis shows for esthetic improv
anesthesia. Error bars represent 95% confidence intervalsthe procedure) exhibited recurrent SV reflux during thefollow-up period. However, clinical recurrence did ap-
pear in 17 limbs in this cohort. This was treated with
phlebectomy in five and was not treated surgically in 12
(Table III).
After stratification of variables, we found a significant
fter ambulatory selective varices ablation under local
ch time point.
t after ambulatory selective varices ablation under local
ch time point.lief aemenlink between the NZT and the postoperative evolution of
nce in
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gence of varices recurrence:
A significant linear trend was observed between the absence
Fig 6. Kaplan-Meier analysis shows for freedom of rec
under local anesthesia. Error bars represent 95% confide
Fig 7. Kaplan-Meier analysis shows for secondary ma
sclerotherapy) after ambulatory selective varices ablation
intervals at each time point.of saphenous reflux in postoperative course and higherNZT (P .037): NZT4, odds ratio (OR), 1; NZT 5,
OR, 0; NZT 6, OR, 9.82; NZT 7, OR, 3.67; NZT7,
OR, 6.81 (Table IV).
A significant linear trend was observed between the symp-
ce of varices after ambulatory selective varices ablation
tervals at each time point.
ntervention (surgical procedure or foam echo-guided
er local anesthesia. Error bars represent 95% confidenceurrenjor i
undtoms relief (P .004) and higher NZT: NZT4, OR,
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1.4; NZT 7, OR, 2.91 (Table V).
A significant linear trend was observed between the emer-
gence of varices recurrence (P  .0001) and higher
NZT: NZT 4, OR, 1; NZT 5, OR, 0.736; NZT 6,
OR, 1.739; NZT 7, OR, 2.826; NZT 7, OR, 4
(Table VI).
Last, when an ostiotruncal saphenous reflux extending
to the malleolus was assessed preoperatively, the presence
of a postoperative nonsignificant SV reflux was less frequent
(47.60% vs 70.30%; P  .05).
DISCUSSION
In this study, the comparison of the patients undergo-
Table III. Follow-up of the 179 limbs for which the
saphenous reflux was nonsignificant (reflux duration 0.5
seconds) at the first postoperative control (6 months)
after ambulatory selective varices ablation under local
anesthesiaa
Variable 6 mon 1 y 2 yrs 3 yrs 4 yrs
No. at risk 179 177 134 123 84
Saphenous reflux
recurrence 0 0 0 0 0
Varices recurrence 0 1 6 6 4
Redo surgery 0 0 0 2 3
aPhlebectomy with preservation of a refluxing saphenous vein.
Table IV. Linear trend between number of treated
zones and nonsignificant saphenous reflux (reflux
duration 0.5 seconds) after stratification of variable
(extended Mantel-Haenszel 2 test)a
A, Recurrence of varices
Stratum 1
NZT
Exposure
level Cases Control Total
Odds of
exp OR
4 0 17 33 50 0.02 1
5 1 20 27 47 0 0
6 2 16 50 66 .2 9.82
7 3 28 39 67 .08 3.97
7 4 6 44 50 .14 6.82
Total 87 193 280
B, Mantel-Haenszel summary OR and crude OR for each
exposure level
Exposure Summary OR Crude OR
Level 0 vs
Level 0 1 1
Level 1 0 0
Level 2 9.821 9.821
Level 3 3.968 3.968
Level 4 6.818 6.818
NZT, Number of zones to treated per limb; OR, odds ratio.
aExtended Mantel-Haenszel 2 for linear trend, 4.33; P1df  .03752.ing ASVAL with those undergoing HLS during the sameperiod clearly favors more limited treatment that preserves
the SV of the patients with a less evolved varicose disease.
This confirms the subjective decision to conserve the SV,
Table V. Linear trend between number of zones treated
and symptoms relief after stratification of variable
(extended Mantel-Haenszel 2 test)a
A, Symptoms improvement
Stratum 1
NZT
Exposure
level Cases Control Total
Odds of
exp OR
4 0 42 8 50 5.38 1
5 1 28 19 47 1.47 .27
6 2 60 6 66 8.57 1.59
7 3 60 7 67 7.5 1.4
7 4 47 3 50 15.67 2.91
Total 237 43 280
B, Mantel-Haenszel summary and crude odds ratios for each
exposure level
Exposure Summary OR Crude OR
Level 0 vs
Level 0 1 1
Level 1 .274 .274
Level 2 1.595 1.595
Level 3 1.395 1.395
Level 4 2.915 2.915
NZT, Number of zones to be treated per limb; OR, odds ratio.
aExtended Mantel-Haenszel 2 linear trend, 7.96; P1df  .004775.
Table VI. Significant linear trend between number of
zones to be treated per limb and varices recurrence after
stratification of variable (extended Mantel-Haenszel 2 test)a
A, Recurrence of varices
Stratum 1
NZT
Exposure
level Cases Control Total
Odds of
exp OR
4 0 33 17 50 1.83 1
5 1 27 20 47 1.35 .74
6 2 50 16 66 3.19 1.74
7 3 57 10 67 5.18 2.83
7 4 44 6 50 7.33 4
Total 211 69 280
B, Mantel-Haenszel summary and crude odds ratios or each
exposure level
Exposure Summary OR Crude OR
Level 0 vs
Level 0 1 1
Level 1 .736 .736
Level 2 1.739 1.739
Level 3 2.826 2.826
Level 4 4 4
NZT, Number of zones to be treated per limb; OR, odds ratio.
aExtended Mantel-Haenszel 2 for linear trend, 14.22; P1df  .0001624.because we did indeed reserve the ASVAL procedure, ap-
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(more frequently asymptomatic C2) and with less extensive
SV reflux. The correlation between the extent of the saphe-
nous reflux, age, and clinical stage is described in the
literature11,17,23 and supports the theory of the develop-
ment of superficial venous insufficiency starting from the
suprafascial venous network in an ascending or multifocal
fashion.5,6,9-11,17,18 Thus, it appeared logical for us to
reserve a more limited surgical treatment for the least
evolved stage of the varicose disease in hopes of obtaining
clinical and hemodynamic reversibility.
We observed postoperative thrombosis of the GSV in
three limbs in which there was a significant difference in the
diameter of the GSV on both sides of the removed varicose
collateral veins, or in which sacciform dilatations of the SV
were present. Thrombosis probably occurred because of
venous stasis in the cul-de-sac in the first situation or in the
venous dilatation in the second situation. In such situa-
tions, consideration must be given to the risk of thrombo-
sis, and preference should be given to ablation of the SV or,
at the very least, to the prescription of anticoagulant treat-
ment postoperatively in the form of low-molecular-weight
heparin at a prophylactic dose during the immediate post-
operative period (8 days).
Our results showed a major change in SV hemodynam-
ics after phlebectomy, in as much as the saphenous reflux
was not significant in more than two-thirds of the limbs
after a mean follow-up of 32.4 months, with a significant
reduction of the SV diameter. Symptoms were clearly im-
proved in limbs for which symptoms were preoperatively
present, with a relief in 78% of the limbs throughout the
follow-up and a significant reduction in the Venous Dis-
ability Score. Other authors reported that simple phlebec-
tomy could change the hemodynamics and the diameter of
the SV24-26 and could provide good clinical results.19,27,28
We previously reported the results obtained after a
7-month follow-up of the same cohort of patients who
underwent an ASVAL operation. These results demon-
strated the functional benefit in terms of the symptoms and
the hemodynamic benefit in terms of the saphenous re-
flux.20 The midterm follow-up of this cohort demonstrated
that the hemodynamic and clinical results remained stable
for the monitored group until year 4.
The hemodynamic results for our cohort can be com-
pared with those of the ablative techniques (either en-
dovenous or surgical) in terms of the persistence or recur-
Table VII. Persistence of saphenous reflux and frequency
the saphenous vein
First author Year Procedure
Patients,
No.
Follow
mo
Merchant14 2005 RFA 1222 5
Nicolini16 2005 RFA 330 3
Creton15 2006 RFA 330 5
RFA, Radiofrequency ablation.rence of a major saphenous reflux; that is, 9.3% at 4 yearsafter life-table analysis for ASVAL vs 15% to 24.5% for
RFA14-16 or EVLA29 and 10% to 15% for HLS30,31 after 3
or 4 years of follow-up, for a population in which the
preoperative frequency of CEAP classification C0 to C3 was
80% (82.7%,14 83%,15,16 91%,29 and 90.1%, in our expe-
rience). Similarly, the incidence of improvement in the
symptoms at 4 years, as observed after ASVAL by life-table
analysis (78%), is comparable to the incidence of improve-
ment obtained after RF (80% to 90%)14-16 or HLS (65% to
80%),30,31 although the patient populations may not be
comparable with our series.
Our study had a broad definition of recurrence because
it included the REVAS criteria22 (ie, the reappearance of
varices in a treated lower limbs regardless of its location).
This broad definition probably explains why only 10 of 24
of varicose recurrences required a supplemental procedure,
because most did not entail any symptoms or any aesthetic
drawbacks. This recurrence frequency of 11.5% at 4 years
after life-table analysis can be compared with the frequency
observed after HLS30,31 (15% to 30%) or after RFA14-16
(22% to 23%) after 3 or 4 years of follow-up. It is highly
noteworthy that for our cohort the recurrences were ac-
companied by an absence of saphenous reflux in 17 of 24
cases, and that the reflux was unchanged compared with the
preoperative situation in only three limbs. This outcome is
comparable with the midterm results of RFA, in which
approximately half of the recurrences appeared despite
permanent obliteration of the SV14-16 (Table VII). This
finding suggests an evolution of the varicose recurrence
from the suprafascial venous network, unrelated to any
persistent or recurrent SV reflux, comparable with the
primitive ascending ormultifocal evolution described in the
literature.6,7,9-11,17,18 This ascending or multifocal physio-
pathologic theory, which challenges the descending evolu-
tion along the saphenous axis according to primary valvular
insufficiency, is based on several observations:
● The frequency of varicose recurrences after surgical or
endovenous ablation of the saphenous vein, which is
from 25% after 5 years, according to Kostkas,32 to 62%
after 11 years, according to Winterborn,33 despite
properly performed stripping; from 22.8% at 3 years,
according to Nicolini,16 to 27.4% after 5 years, accord-
ing to Merchant,14 after endovenous RFA treatment,
despite the obliteration of the SV in more than 83% of
cases. Perrin34 reported that in 63.7% of cases, there is
rices recurrence at midterm after endovenous ablation of
Patients at end of
follow-up, No.
Persistence
of SR, %
Frequency of varices
recurrence, %
406 12.8% 27.4
68 12.0% 22.8
103 15.0% 27.0of va
-up,
nmore than one source of reflux when a poststripping
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recurrence involves the saphenous confluence.
● The disappearance of ostial reflux after endovenous
treatment, despite the absence of crossectomy, in
93.4% of cases, according to Min35; after EVLA treat-
ment in 95.7% of cases, according to Proebstle36; and
after RFA in 88.2% of cases, according to Merchant,14
or in 90.9% of the latter cases, according to Pichot.37
● The reduction in saphenous reflux, which in our expe-
rience is no longer significant (0.5 seconds) after
phlebectomies in more than two-thirds of the limbs.
This finding may be due to the reduction in the size of
the saphenous vein (which, in this study, is significant
in the region of the saphenous confluence), thereby
making it possible to detect whether the values were
leakproof.
Lurie38 suggested the possibility of functional insuffi-
ciency of the saphenous valves in the absence of any ana-
tomic lesions. The closing of the valves would be caused by
the existing pressure in the valvular sinus, which pressure
would increase in direct proportion to the velocity of the
anterograde flow. If this velocity fails to reach a critical
value that allows pressure to be obtained that is sufficient to
close the valve, the valve will not close. This is why a reflux
may be present that passes through healthy valves when a
patient is in the decubitus position, because the velocity of
the anterograde flow is slight. Because ablation of the
varicose reservoir makes it possible to improve the saphe-
nous hemodynamics, it may also make it possible to elimi-
nate a functional valvular insufficiency by increasing the
anterograde velocity.
Numerous biochemical and anatomopathologic stud-
ies suggest a parietal, rather than valvular, hypothesis for
varicose disease.39-41 According to this hypothesis, valvular
insufficiency is caused by the dilatation of the vein. Anato-
moclinical studies indicate that in the presence of varices,
not only is the saphenous confluence continent in50% of
cases,4,8 but, moreover, the SV is often partially or wholly
continent.10,11
All of these observations collectively challenge the
sole culpability of the SV in the initial development of
saphenous-vein disease.
The midterm follow-up of our cohort treated by
ASVAL made it possible to detect the central role played by
the varicose reservoir with regard to postoperative evolu-
tion. We found a significant link between the NZT, im-
provement of symptoms (NZT 7; OR, 2.91; P  .004),
and absence of postoperative SV reflux (NZT 7; OR, 4;
P  .037), probably because the resection of a large vari-
cose reservoir is more likely to improve symptoms and
hemodynamics of the SV. Conversely, the lower limbs that
underwent resection of an extended varicose reservoir were
more frequently subject to the onset of a varicose recur-
rence (NZT 7; OR, 6.82; P  .0001), probably because
this was the mark of evolving varicose disease. This means
that lower limbs with an extended varicose reservoir shouldbe followed up with more rigorous monitoring, regardless
of the treatment administered.
Finally, when the SV reflux reaches the malleolus, an
improvement in this reflux is less expected in accordance
with the principle of the elimination of the aspiration effect
because the option of treating an underlying varicose res-
ervoir is no longer available. In our study, the presence of a
preoperative saphenous reflux extending to the malleolus
was significantly associated with the persistence of a signif-
icant SV reflux during the postoperative period (52.4% vs
29.7%; P  .05).
In the literature, the judgment criterion applied after a
treatment for varices usually consists of the evolution of the
SV reflux or the evolution of the symptomatology, but the
evolution of the varicose reservoir is never taken into con-
sideration. However, our results show that it appears to
play a major role in the indication of the treatment and in
postoperative evolution. Nevertheless, it should be noted
that we do not currently have a reliable and valid criterion
for the evaluation of varicose reservoir.
In contrast to our approach, certain other authors
advocate a treatment limited to RFA42 or EVLA,43 which
led to spontaneous regression of the varices in 28% to 65%
of cases after the obliteration of the SV, with no interven-
tion affecting the varicose reservoir, albeit with a short
follow-up of 3 to 9 months, and with secondary treatment
(foam sclerotherapy, phlebectomy, stripping) for residual
varices in 17% to 62.5%. Thus, no conclusions can be
offered regarding the mid- or long-term evolution of the
SV disease after this type of treatment, which is limited to
the saphenous axis.
No treatment can characterize itself as “radical” with
regard to the treatment of varices, probably because the
natural history of varicose disease differs from patient to
patient, thereby calling into question the traditional de-
scending physiopathologic dogma. Consequently, regard-
less of the treatment technique, it is logical to contemplate
a long-term follow-up for the patients treated for varices,
with the adaptation of the procedures and the choice of
techniques on a case-by-case basis and with the abandon-
ment of invariable and needlessly destructive treat-
ments.44-47 Within this context, the choice of a treatment
limited to phlebectomy—even in the presence of saphe-
nous reflux—may be the first-line treatment apart from the
evolved stages because it is minimally invasive, focuses on
the varicose reservoir, and respects the saphenous axis,
whose recuperative potential—as our study has shown—is
far from negligible. Preservation of the SV, whose physio-
logic role may perhaps have been discounted, should be an
important factor in the long-term management of varicose
disease.
CONCLUSIONS
The performance of isolated phlebectomy with the
conservation of a refluxing SV may be effective over the
midterm against the symptoms of superficial venous insuf-
ficiency, for the disappearance of the varices, and for saphe-
nous hemodynamics, with a nonsignificant postoperative
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 1 Pittaluga et al 117reflux in two-thirds of limbs. The magnitude of the volume
of the varicose reservoir appears to be the determining
factor for the clinical and hemodynamic efficacy of this
more limited surgical approach. Further studies—includ-
ing, in particular, prospective studies—will be necessary to
obtain clearer definition of the indications for this thera-
peutic approach, to evaluate the SV with regard to long-
term evolution, and to identify a reliable criterion for the
evaluation of the varicose reservoir.
AUTHOR CONTRIBUTIONS
Conception and design: PP, SC
Analysis and interpretation: PP
Data collection: PP, BR, RB
Writing the article: PP, SC
Critical revision of the article: PP, SC
Final approval of the article: PP, SC
Statistical analysis: PP
Obtained funding: Not applicable
Overall responsibility: PP
REFERENCES
1. Trendelenburg F. Ueber die Unterbindung der Vena Saphena magna
bei Unterschenkel Varicen. Beitr Z Klin Chir 1890;7:195-210.
2. Ludbrook J, Beale G. Femoral venous valves in relation to varicose
veins. Lancet 1962 13;1:79-81.
3. Cotton LT. Varicose veins. Gross anatomy and development. Br J Surg
1961;48:589-98.
4. Abu-Own A, Scurr JH, Coleridge Smith PD. Saphenous vein reflux
without incompetence at the saphenofemoral junction. Br J Surg 1994;
81:1452-4.
5. Myers KA, Ziegenbein RW, Zeng GH, Matthews PG. Duplex ultra-
sonography scanning for chronic venous disease: patterns of venous
reflux. J Vasc Surg 1995;21:605-12.
6. Labropoulos N, Giannoukas AD, Delis K, Mansour MA, Kang SS,
Nicolaides AN, Lumley J, Baker WH. Where does venous reflux start? J
Vasc Surg 1997;26:736-42.
7. Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Buckman J,
Baker WH. Primary superficial vein reflux with competent saphenous
trunk. Eur J Vasc Endovasc Surg 1999;18:201-6.
8. Cooper DG, Hillman-Cooper CS, Barker SG, Hollingsworth SJ. Pri-
mary varicose veins: the sapheno-femoral junction, distribution of var-
icosities and patterns of incompetence. Eur J Vasc Endovasc Surg
2003;25:53-9.
9. Labropoulos N, Leon L, Kwon S, Tassiopoulos A, Gonzalez-Fajardo
JA, Kang SS, Mansour MA, Littooy FN. Study of the venous reflux
progression. J Vasc Surg 2005;41:291-5.
10. Engelhorn CA, Engelhorn AL, Cassou MF, Salles-Cunha SX. Patterns
of saphenous reflux in women with primary varicose veins. J Vasc Surg
2005;41:645-51.
11. Pittaluga P, Chastanet S. Classification of saphenous refluxes: implica-
tions for treatment. Phlebology 2008;23:2-9.
12. Mayo CH. Treatment of varicose vein. Surg Gyn Obst Br J Surg
1906;2:385-8.
13. Babcock WW. A new operation for the extirpation of varicose veins of
the leg. N Y Med J 1907;86:153-6.
14. Merchant RF, Pichot O. Long-term outcomes of endovenous radiofre-
quency obliteration of saphenous reflux as a treatment for superficial
venous insufficiency. J Vasc Surg 2005;42:502-9.
15. Creton D et le Groupe Closure®. Oblitération Tronculaire Saphène par
le Procédé Radiofréquence Closure: Résultats à 5 Ans de l’Etude
Prospective Multicentrique. Phlébologie 2006;59:67-72.
16. Nicolini P, Closure® Group. Treatment of primary varicose veins by
endovenous obliteration with the VNUS Closure system: results of aprospective multicentre study. Eur J Vasc Endovasc Surg 2005;29:
433-9.
17. Caggiati A, Rosi C, Heyn R, Franceschini M, Acconcia MC. Age-
related variations of varicose veins anatomy. J Vasc Surg 2006;44:
1291-5.
18. Pittaluga P, Chastanet S. The lesser importance of the saphenous vein in
therapy of varicose veins. In: Bergan JJ, editor. Foam sclerotherapy.
London: The Royal Society of Medicine Press; 2008. pp 163-76.
19. Muller R. Traitement des varices par phlébectomie ambulatoire.
Phlébologie 1966;19:277-9.
20. Pittaluga P, Rea B, Barbe R. Méthode ASVAL (Ablation Sélective des
Varices sous Anesthésie Locale): principes et résultats préliminaires.
Phlébologie 2005;2:175-81.
21. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner
MH, Moneta GL. Venous severity scoring: an adjunct to venous
outcome assessment. J Vasc Surg 2000;31:1307-12.
22. Perrin M, Guex JJ, Ruckley CV, De Palma RG, Royle JP, Eklof B, et al.
Recurrent varices after surgery (REVAS): a consensus document. Car-
diovasc Surg 2000;8:233-45.
23. Labropoulos N, Leon M, Nicolaides AN, Giannoukas AD, Volteas N,
Chan P. Superficial venous insufficiency: correlation of anatomic extent
of reflux with clinical symptoms and signs. J Vasc Surg 1994;20:953-8.
24. Vidal-Michel JP, Bourrel Y, Emsallem J, Bonerandi JJ. Respect chirur-
gical des crosses saphènes internes modérement incontinentes par
«effect siphon» chez les patients variqueux. Phlébologie 1993;1:143-7.
25. Creton D. Diamater reduction of the proximal long saphenous vein
after ablation of a distal incompetent tributary. Dermatol Surg 1999;
25:394-7.
26. Zamboni P, Cisno C, Marchetti F, Quaglio D, Mazza P, Liboni A.
Reflux elimination without any ablation or disconnection of the saphe-
nous vein. A haemodynamic model for venous surgery. Eur J Vasc
Endovasc Surg 2001;21:361-9.
27. Large J. Surgical treatment of saphenous varices, with preservation of
the main great saphenous trunk. J Vasc Surg 1985;2:886-91.
28. Ricci S, Georgiev M, Goldman MP. Phlebectomy. Vein avulsion. In
Ricci S, Georgiev M, Goldman MP, editors. Ambulatory phlebectomy,
2nd ed. Boca Raton: Taylor and Francis; 2005. pp 121-33.
29. Myers KA, Jolley D. Outcome of endovenous laser therapy for saphe-
nous reflux and varicose veins: medium-term results assessed by ultra-
sound surveillance. Eur J Vasc Endovasc Surg 2009;37:239-45.
30. Rutgers PH, Kitslaar PJ. Randomized trial of stripping versus high
ligation combined with sclerotherapy in the treatment of the incompe-
tent greater saphenous vein. Am J Surg 1994;168:311-5.
31. Jones L, Braithwaite BD, Selwyn D, Cooke S, Earnshaw JJ. Neovascu-
larisation is the principal cause of varicose vein recurrence: result of a
randomised trial of stripping the long saphenous vein. Eur J Vasc
Endovasc Surg 1996;12:442-5.
32. Kostas T, Ioannou CV, Touloupakis E, Daskalaki E, Giannoukas AD,
Tsetis D, et al. Recurrent varicose veins after surgery: a new appraisal of
a common and complex problem in vascular surgery. Eur J Vasc
Endovasc Surg 2004;2:275-82.
33. Winterborn RJ, Foy C, Earnshaw JJ. Causes of varicose vein recurrence:
late results of a randomized controlled trial of stripping the long
saphenous vein. J Vasc Surg 2004;40:634-9.
34. Perrin MR, Labropoulos N, Leon LR Jr. Presentation of the patient
with recurrent varices after surgery (REVAS). J Vasc Surg 2006;43:
327-34.
35. Min RJ, Zimmet SE, Isaacs MN, Forrestal MD. Endovenous laser
treatment of the incompetent greater saphenous vein. J Vasc Interv
Radiol 2001;12:1167-71.
36. Proebstle TM, Moehler T, Herdemann S. Reduced recanalization rates
of the great saphenous vein after endovenous laser treatment with
increased energy dosing: definition of a threshold for the endovenous
fluence equivalent. J Vasc Surg 2006;44:834-9.
37. Pichot O, Kabnick LS, Creton D, Merchant RF, Schuller-Petroviae S,
Chandler JG. Duplex ultrasound scan findings two years after great
saphenous vein radiofrequency endovenous obliteration. J Vasc Surg
2004;39:189-95.
JOURNAL OF VASCULAR SURGERY
July 2009118 Pittaluga et al38. Lurie F. New investigations for venous valve insufficiency: perspective
for early detection. Presented at: Ninth Annual Meeting of the Euro-
pean Venous Forum, Barcelona, Spain, Jun 26-28, 2008.
39. Porto LC, da Silveira PR, de Carvalho JJ, PanicoMD. Connective tissue
accumulation in the muscle layer in normal and varicose saphenous
veins. Angiology 1995;46:243-9.
40. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson
MD. Analysis of the connective tissue matrix and proteolytic activity of
primary varicose veins. J Vasc Surg 1993;18:814-20.
41. Lengyel I, Acsády G. Histomorphological and pathobiochemical
changes of varicose veins. A possible explanation of the development of
varicosis. Acta Morphol Hung 1990;38:259-67.
42. Welch HJ. Endovenous ablation of the great saphenous vein may avert
phlebectomy for branch varicose veins. J Vasc Surg 2006;44:601-5.
43. Theivacumar NS, Dellagrammaticas D, Mavor AI, Gough MJ. En-ablation provide optimum results in patients with both above- and
below-knee reflux? A randomized controlled trial. J Vasc Surg
2008;48:173-8.
44. Schanzer H, Skladany M. Varicose vein surgery with preservation of the
saphenous vein: a comparison between high ligation-avulsion versus
saphenofemoral banding valvuloplasty-avulsion. J Vasc Surg 1994;20:
684-7.
45. de Ross KP, Nieman FH, Neumann HA. Ambulatory phlebectomy
versus compression sclerotherapy: results of a randomized controlled
trial. Dermatol Surg 2003;29:221-6.
46. Pittaluga P, Marionneau N, Creton D, Lefebvre-Vilardebo M, Rea B,
Sala F, et al. Traitement chirurgical des varices des membres inférieurs:
approche moderne. Phlébologie 2004;3:149-156.
47. Creton D. Faire moins pour faire mieux. Phlébologie 2006;59:67-72.dovenous laser ablation: does standard above-knee great saphenous vein Submitted Sep 24, 2008; accepted Dec 23, 2008.
